Published in J Pharmacokinet Biopharm on June 01, 1984
Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group. Circulation (1990) 2.22
Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure. Circulation (2000) 1.69
Fatal hemorrhage as a complication of neurofibromatosis. Vasc Surg (1972) 1.67
Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation (2000) 1.63
Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol (1984) 1.57
Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure. Circulation (1983) 1.51
Influence of positive inotropic therapy on pulsatile hydraulic load and ventricular-vascular coupling in congestive heart failure. J Am Coll Cardiol (1990) 1.44
Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol (1992) 1.41
Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation (1978) 1.35
Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. Am J Cardiol (1986) 1.32
Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics. J Pharmacol Exp Ther (1981) 1.28
Aorto-left atrial fistula. A reversible cause of acute refractory heart failure. Chest (1997) 1.23
Human myocardial histologic characteristics in congestive heart failure. Circulation (1983) 1.23
The arrhythmogenic effects of caffeine in human beings. N Engl J Med (1983) 1.22
Cocaine-induced coronary-artery dissection. N Engl J Med (1994) 1.21
Prolonged atrial conduction. A major predisposing factor for the development of atrial flutter. Circulation (1978) 1.20
Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. Circulation (1984) 1.18
Tolerance to dobutamine after a 72 hour continuous infusion. Am J Med (1980) 1.17
Cardiovascular abnormalities associated with adult polycystic kidney disease. Ann Intern Med (1984) 1.16
The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure. Circulation (1977) 1.15
Captopril in primary pulmonary hypertension. Circulation (1983) 1.12
Altered collagen composition in a prolapsing mitral valve with ruptured chordae tendineae. Am J Med (1979) 1.12
Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion. Circulation (1979) 1.12
Cardiovascular effects of ophthalmic timolol. Ann Intern Med (1986) 1.10
Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol (1993) 1.09
Hemodynamic changes after meals and placebo treatment in chronic congestive heart failure. Am J Cardiol (1986) 1.07
Studies on retinal blood flow. II. Diabetic retinopathy. Arch Ophthalmol (1978) 1.07
High-pressure liquid chromatography analysis and single-dose disposition of tobramycin in human volunteers. Antimicrob Agents Chemother (1980) 1.07
Allopurinol sensitivity: report of two cases. Am J Hosp Pharm (1979) 1.06
Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension. Ann Intern Med (1982) 1.04
The spectrum of cardiac defects in the Ehlers-Danlos syndrome, types I and III. Ann Intern Med (1980) 1.04
The hemodynamic effects of ibopamine, a dopamine congener, in patients with congestive heart failure. Pharmacotherapy (1986) 1.02
Drugs five years later. Dobutamine. Ann Intern Med (1983) 1.02
Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose. Ann Intern Med (1981) 1.01
Dissimilar atrial rhythms. A patient with interatrial block. Br Heart J (1977) 1.01
Liquid chromatographic analysis of disopyramide and its mono-N-dealkylated metabolite. Clin Chem (1979) 0.97
Quantitative investigation of cardiomyocyte hypertrophy and myocardial fibrosis over 6 years after cardiac transplantation. J Am Coll Cardiol (1998) 0.96
Persistent left superior vena cava: unusual wave contour of left jugular vein as the presenting feature. Am Heart J (1990) 0.96
Sequential single doses of cisapride, erythromycin, and metoclopramide in critically ill patients intolerant to enteral nutrition: a randomized, placebo-controlled, crossover study. Crit Care Med (2000) 0.96
Protein binding of disopyramide and elevated alpha-1-acid glycoprotein concentrations in serum obtained from dialysis patients and renal transplant recipients. Am J Nephrol (1985) 0.95
HLA-DQ strikes again: genome-wide association study further confirms HLA-DQ in the diagnosis of asthma among adults. Clin Exp Allergy (2012) 0.95
Low exhaled nitric oxide and a polymorphism in the NOS I gene is associated with acute chest syndrome. Am J Respir Crit Care Med (2001) 0.94
Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study. J Am Coll Cardiol (1984) 0.93
Interatrial conduction (activation) times. Am J Cardiol (1979) 0.93
The noninvasive localization of ventricular pacing sites by radionuclide phase imaging. Circulation (1984) 0.92
Nitrate tolerance. Am Heart J (1985) 0.92
Contamination of albumin by alpha 1-acid glycoprotein. Biochem Pharmacol (1981) 0.91
Magnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure. Circulation (1989) 0.91
The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy. Am Heart J (1983) 0.90
Hemodynamic-inotropic response to beta-blocker with intrinsic sympathomimetic activity in patients with congestive cardiomyopathy. Circulation (1986) 0.89
Two-compartment gentamicin pharmacokinetics in premature neonates: a comparison to adults with decreased glomerular filtration rates. J Pediatr (1980) 0.89
Stereoselective effects of disopyramide enantiomers in humans. J Cardiovasc Pharmacol (1987) 0.89
25-hydroxy vitamin D levels are associated with childhood asthma in a population-based study in Peru. Clin Exp Allergy (2015) 0.89
Early changes in human myocardial nuclei after doxorubicin. Cancer (1983) 0.88
Effect of citrus juice and SLCO2B1 genotype on the pharmacokinetics of montelukast. J Clin Pharmacol (2010) 0.88
Effect of increased adrenergic activity on the relationship between electrical and mechanical systole. Circulation (1981) 0.88
The effect of left atrial histology and dimension on P wave morphology. J Electrocardiol (1983) 0.88
Predicting inhaled corticosteroid response in asthma with two associated SNPs. Pharmacogenomics J (2012) 0.87
Racial differences in propranolol enantiomer kinetics following simultaneous i.v. and oral administration. Br J Clin Pharmacol (1996) 0.86
Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure. Am J Cardiol (1980) 0.86
Doxorubicin cardiotoxicity. Cancer Treat Rev (1982) 0.86
Comparison of cisapride and metoclopramide for facilitating gastric emptying and improving tolerance to intragastric enteral nutrition in critically III, mechanically ventilated adults. Clin Ther (2001) 0.86
Central and regional hemodynamic effects of flosequinan for congestive heart failure. Am J Cardiol (1989) 0.86
Postoperative pericarditis following thymectomy for myasthenia gravis. A prospective study. Chest (1983) 0.86
Influence of volume shifts on drug binding during equilibrium dialysis: correction and attenuation. J Pharmacokinet Biopharm (1983) 0.85
Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug. J Pharmacol Exp Ther (1984) 0.85
Rest and exercise cardiovascular effects of terazosin in congestive heart failure. Am J Cardiol (1990) 0.85
A polymorphism in the thyroid hormone receptor gene is associated with bronchodilator response in asthmatics. Pharmacogenomics J (2012) 0.85
Pharmacogenetics of asthma controller treatment. Pharmacogenomics J (2012) 0.84
ALOX5 polymorphism associates with increased leukotriene production and reduced lung function and asthma control in children with poorly controlled asthma. Clin Exp Allergy (2013) 0.84
Cardiac function in Duchenne's muscular dystrophy. Results of 10-year follow-up study and noninvasive tests. Am J Med (1982) 0.84
Drug-induced conditioning in congestive heart failure. Circulation (1982) 0.84
Temporary atrial standstill. Am Heart J (1979) 0.83
Placebo treatment in congestive heart failure. Cardiology (1992) 0.83
Amrinone therapy for congestive heart failure in outpatients with idiopathic dilated cardiomyopathy. Am J Cardiol (1983) 0.83
Long-term benefit of dobutamine in patients with congestive cardiomyopathy. Am Heart J (1980) 0.83
The influence of blood collection technique on serum and plasma protein binding of disopyramide. Eur J Clin Pharmacol (1982) 0.83
An electrophysiologic study of swallowing-induced tachycardia. Chest (1978) 0.83
Serum and tissue magnesium concentrations in patients with heart failure and serious ventricular arrhythmias. Ann Intern Med (1990) 0.82
The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy. Am Heart J (1983) 0.82
An analysis of the determinants of exercise performance in congestive heart failure. Am Heart J (1987) 0.82
A paucity of chronic electrocardiographic changes with adriamycin therapy. J Electrocardiol (1978) 0.82
Evaluation of fluorescence immunoassay for total and unbound serum concentrations of disopyramide. Ther Drug Monit (1984) 0.82
Medical therapy of end-stage congestive and ischemic cardiomyopathy. Cardiovasc Clin (1988) 0.82
Diastolic time in congestive heart failure. Am Heart J (1987) 0.82
Development of pharmacodynamic tolerance to prozosin in congestive heart failure. Am J Cardiol (1979) 0.82
Increased diastolic time: a possible important factor in the benefical effect of propranolol in patients with coronary artery disease. J Cardiovasc Pharmacol (1980) 0.82
Autonomic tone of patients during an electrophysiological catheterization. The role of autonomic influences on the reproducibility of sinus node function studies. Am Heart J (1980) 0.82
Usefulness of a free radical scavenger in preventing doxorubicin-induced heart failure in dogs. Am J Cardiol (1985) 0.82
A comparison of methods of lidocaine administration in patients. Clin Pharmacol Ther (1981) 0.81
Position as a variable for cardiovascular responses during exercise. Clin Cardiol (1987) 0.81
Dobutamine increases cardiac output of the total artificial heart. Implications for vascular contribution of inotropic agents to augmented ventricular function. Circulation (1991) 0.81
The electrophysiologic effects of upright posture. Am Heart J (1984) 0.81
Prevalence and risk factors for allergic rhinitis in two resource-limited settings in Peru with disparate degrees of urbanization. Clin Exp Allergy (2015) 0.80
Prevention of bedrest-induced physical deconditioning by daily dobutamine infusions. Implications for drug-induced physical conditioning. J Clin Invest (1985) 0.80
Stereoselective binding of disopyramide to human plasma protein. Life Sci (1984) 0.80